Johan De Mey

Johan De Mey

Auto-generated profile, based on publicly available information

Johan De Mey

Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in European Journal of Neurology
Verified
Journal Article
Open access
SDStijn Denissen
Stijn Denissen
DEDenis-Alexander Engemann
Denis-Alexander Engemann
ACAlexander De Cock
Alexander De Cock
LCLars Costers
Lars Costers
JBJohan Baijot
Johan Baijot
GNGuy Nagels
Guy Nagels
Background and purpose: Data from neuro‐imaging techniques allow us to estimate a brain's age. Brain age is easily interpretable as ‘how old the brain looks’ and could therefore be an attractive communication tool for brain health in clinical practice. This study aimed to investigate its clinical utility by investigating the relationship between brain age and cognitive performance in multiple sclerosis (MS).Methods: A linear regression model was trained to predict age from brain magnetic resonance imaging volumetric features and sex in a healthy control dataset (HC_train, n = 1673). This model was used to predict brain age in two test sets: HC_test (n = 50) and MS_test (n = 201). Brain‐predicted age difference (BPAD) was calculated as BPAD = brain age minus chronological age. Cognitive performance was assessed by the Symbol Digit Modalities Test (SDMT).Results: Brain age was significantly related to SDMT scores in the MS_test dataset (r = −0.46, p < 0.001) and contributed uniquely to variance in SDMT beyond chronological age, reflected by a significant correlation between BPAD and SDMT (r = −0.24, p < 0.001) and a significant weight (−0.25, p = 0.002) in a multivariate regression equation with age.Conclusions: Brain age is a candidate biomarker for cognitive dysfunction in MS and an easy to grasp metric for brain health.

1 June 2016 in British Journal of Radiology
Verified
Journal Article
Closed access
CBCedric Boulet
Cedric Boulet
HMHardi Madani
Hardi Madani
LLLeon Lenchik
Leon Lenchik
FVFilip Vanhoenacker
Filip Vanhoenacker
DADeepak S Amalnath
Deepak S Amalnath
MMMichel De Maeseneer
Michel De Maeseneer
There is a wide variety of hereditary and non-hereditary bone dysplasias, many with unique radiographic findings. Hereditary bony dysplasias include osteopoikilosis, osteopathia striata, osteopetrosis, progressive diaphyseal dysplasia, hereditary multiple diaphyseal sclerosis, and pyknodysostosis. Non-hereditary dysplasias include melorheostosis, intramedullary osteosclerosis and overlap syndromes. Although many of these dysplasias are uncommon, radiologists should be familiar with their genetic, clinical and imaging findings to allow for differentiation from acquired causes of bony sclerosis. We present an overview of hereditary and non-hereditary bony dysplasias with focus on pathogenesis, clinical and radiographic findings of each disorder.

7 April 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
PSPatrick Serruys
Patrick Serruys
SKShigetaka Kageyama
Shigetaka Kageyama
Giulio PompilioGiulio Pompilio
Giulio Pompilio
DADaniele Andreini
Daniele Andreini
Gianluca PontoneGianluca Pontone
Gianluca Pontone
YOYoshinobu Onuma
Yoshinobu Onuma
Background and Aims: In patients with three-vessel disease and/or left main disease, selecting revascularization strategy based on coronary computed tomography angiography (CCTA) has a high level of virtual agreement with treatment decisions based on invasive coronary angiography (ICA).Methods: In this study, coronary artery bypass grafting (CABG) procedures were planned based on CCTA without knowledge of ICA. The CABG strategy was recommended by a central core laboratory assessing the anatomy and functionality of the coronary circulation. The primary feasibility endpoint was the percentage of operations performed without access to the ICA. The primary safety endpoint was graft patency on 30-day follow-up CCTA. Secondary endpoints included topographical adequacy of grafting, major adverse cardiac and cerebrovascular (MACCE), and major bleeding events at 30 days. The study was considered positive if the lower boundary of confidence intervals (CI) for feasibility was ≥75% (NCT04142021).Results: The study enrolled 114 patients with a mean (standard deviation) anatomical SYNTAX score and Society of Thoracic Surgery score of 43.6 (15.3) and 0.81 (0.63), respectively. Unblinding ICA was required in one case yielding a feasibility of 99.1% (95% CI 95.2%–100%). The concordance and agreement in revascularization planning between the ICA- and CCTA-Heart Teams was 82.9% with a moderate kappa of 0.58 (95% CI 0.50–0.66) and between the CCTA-Heart Team and actual treatment was 83.7% with a substantial kappa of 0.61 (95% CI 0.53–0.68). The 30-day follow-up CCTA in 102 patients (91.9%) showed an anastomosis patency rate of 92.6%, whilst MACCE was 7.2% and major bleeding 2.7%.Conclusions: CABG guided by CCTA is feasible and has an acceptable safety profile in a selected population of complex coronary artery disease.

6 January 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
IWInneke Willekens
Inneke Willekens
ECElke Van de Casteele
Elke Van de Casteele
NBNico Buls
Nico Buls
FTFrederik Temmermans
Frederik Temmermans
BJBart Jansen
Bart Jansen
JMJohan de Mey
Johan de Mey
Detection of microcalcifications on mammograms indicates the presence of breast lesion, and the shapes of the microcalcifications as seen by conventional mammography correlates with the probability of malignancy. This preliminary study evaluated the 3D shape of breast microcalcifications using micro-computed tomography (micro-CT) and compared the findings with those obtained using anatomopathological analysis.

30 July 2015 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
MSMaryam Shahabpour
Maryam Shahabpour
BSBarbara Staelens
Barbara Staelens
LOLuc Van Overstraeten
Luc Van Overstraeten
MMMichel De Maeseneer
Michel De Maeseneer
CBCedric Boulet
Cedric Boulet
Thierry ScheerlinckThierry Scheerlinck
Thierry Scheerlinck

28 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
MLMaria-Luiza Luchian
Maria-Luiza Luchian
AMAndreea Motoc
Andreea Motoc
SLStijn Lochy
Stijn Lochy
JMJulien Magne
Julien Magne
DBDries Belsack
Dries Belsack
BCBernard Cosyns
Bernard Cosyns
Long coronavirus disease 2019 (COVID-19) was described in patients recovering from COVID-19, with dyspnea being a frequent symptom. Data regarding the potential mechanisms of long COVID remain scarce. We investigated the presence of subclinical cardiac dysfunction, assessed by transthoracic echocardiography (TTE), in recovered COVID-19 patients with or without dyspnea, after exclusion of previous cardiopulmonary diseases. A total of 310 consecutive COVID-19 patients were prospectively included. Of those, 66 patients (mean age 51.3 ± 11.1 years, almost 60% males) without known cardiopulmonary diseases underwent one-year follow-up consisting of clinical evaluation, spirometry, chest computed tomography, and TTE. From there, 23 (34.8%) patients reported dyspnea. Left ventricle (LV) ejection fraction was not significantly different between patients with or without dyspnea (55.7 ± 4.6 versus (vs.) 57.6 ± 4.5, p = 0.131). Patients with dyspnea presented lower LV global longitudinal strain, global constructive work (GCW), and global work index (GWI) compared to asymptomatic patients (−19.9 ± 2.1 vs. −21.3 ± 2.3 p = 0.039; 2183.7 ± 487.9 vs. 2483.1 ± 422.4, p = 0.024; 1960.0 ± 396.2 vs. 2221.1 ± 407.9, p = 0.030). GCW and GWI were inversely and independently associated with dyspnea (p = 0.035, OR 0.998, 95% CI 0.997–1.000; p = 0.040, OR 0.998, 95% CI 0.997–1.000). Persistent dyspnea one-year after COVID-19 was present in more than a third of the recovered patients. GCW and GWI were the only echocardiographic parameters independently associated with symptoms, suggesting a decrease in myocardial performance and subclinical cardiac dysfunction.